Lifecore Biomedical, Inc. (LFCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 5.54 |
| Open | 5.62 |
| Day High | 5.65 |
| Day Low | 5.48 |
| 52-Week High | 8.98 |
| 52-Week Low | 3.63 |
| Volume | 124,645 |
| Average Volume | 262,217 |
| Market Cap | 207.43M |
| PE | -4.35 |
| EPS | -1.27 |
| Moving Average 50 Days | 5.11 |
| Moving Average 200 Days | 6.59 |
| Change | -0.01 |
Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum
GlobeNewswire Inc.
Mar 10, 2026 8:05 PM GMT
CHASKA, Minn., March 10, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate
Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026
GlobeNewswire Inc.
Mar 09, 2026 8:05 PM GMT
Webcast Scheduled for Monday, March 16 at 8:30 a.m. EasternCHASKA, Minn., March 09, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (
Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment
GlobeNewswire Inc.
Mar 04, 2026 9:03 PM GMT
Indomo Developing Fast-Acting, At-Home Treatment for Inflammatory Acne Lesions to be Administered with the ClearPen™, its Proprietary Intradermal Self-Injection Device Lifecore to Manufacture Drug Batches in Preparation for Planned Clinical Trials C